Results 31 to 40 of about 12,304,496 (201)
Brazilian Journal of Infectious Diseases, 2017 Meningococcal carriage is a prerequisite for invasive infection. This cross-sectional study assessed the pharyngeal carriage prevalence in healthy subjects aged 1–24 years in Embu das Artes city, São Paulo, Brazil.
Lily Yin Weckx +8 more
doaj +1 more source
DNA methylation assessed by SMRT sequencing is linked to mutations in Neisseria meningitidis isolates [PDF]
, 2015 The Gram-negative bacterium Neisseria meningitidis features extensive genetic variability. To present, proposed virulence genotypes are also detected in isolates from asymptomatic carriers, indicating more complex mechanisms underlying variable ...
Gerd Pluschke +26 more
core +1 more source
Chemoenzymatic Synthesis of Well‐Defined α(2,8)‐ and α(2,9)‐Linked Oligosialosides
Angewandte Chemie, Volume 138, Issue 36, 1 September 2026.Well‐defined α(2,8)‐ and α(2,9)‐linked oligosialic acids of different lengths can be prepared by employing recombinant bacterial polysialyltransferases in combination with chemically modified CMP‐Neu5Ac derivatives. After transfer, a sialoside is formed bearing an artificial entity, which blocks further glycosylation.
Jelle A. Fok +4 more
wiley +2 more sources
Microbiologia Medica, 2012 Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b cause the majority of cases of bacterial septicaemia in children and young adults.
Laura Daprai +9 more
doaj +1 more source
Emerging Infectious Diseases, 2016 Serum samples from children immunized with a meningococcal serogroup B vaccine demonstrated potent serum bactericidal antibody activity against the hypervirulent Neisseria meningitidis serogroup W strain circulating in England. The recent introduction of
Shamez Ladhani +8 more
doaj +1 more source
Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
npj Vaccines, 2021 Infections with Neisseria meningitidis and Neisseria gonorrhoeae have different clinical manifestations, but the bacteria share up to 80–90% genome sequence identity.
Yara Ruiz García +9 more
doaj +1 more source
Towards an improved serogroup BNeisseria meningitidisvaccine
Expert Opinion on Biological Therapy, 2005 Meningococcal disease, presenting primarily as septicaemia and meningitis, continues to be a devastating problem around the world. Over the last century, vaccine development has been undertaken in earnest for the prevention of this disease. Polysaccharide vaccines have been available for almost 40 years, yet they are poorly immunogenic in young ...
Perrett, K, Pollard, A
openaire +2 more sources
Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis [PDF]
The Journal of Immunology, 2005 Abstract Neisseria meningitidis (meningococcus) is an important cause of meningitis and sepsis. Currently, there is no effective vaccine against serogroup B meningococcal infection. Host defense against neisseriae requires the complement system (C) as indicated by the fact that individuals deficient in properdin or late C components ...
Hanna, Jarva +4 more
openaire +2 more sources
Molecular epidemiology of meningococcal disease in Northern Ghana [PDF]
, 2001 Meningococcal disease remains a major public health concern, especially in the African Meningitis Belt where large meningitis epidemics with attack rates of up to 500/100,000 recur every 8-12 years.
Gagneux, Sébastien
core +1 more source
Meningococcal Carriage among College Freshmen in Kashmir, North India- A Single Centre Study [PDF]
Journal of Clinical and Diagnostic Research, 2017 Introduction: Data on the community carriage of meningococci in developing countries are sparse. Knowledge about the same would help identify demographic and socio-behavioural risk factors, the need for infection control strategies and the composition of
Nargis K Bali +5 more
doaj +1 more source